NMDA Receptors

Items 1-50 of 209

Page
per page
Set Descending Direction
Catalog No.
Product Name
Application
Product Information
Citations
  1. NMDA receptor ion channel antagonist

    ARL-15896 is a novel N-methyl-D-aspartate receptor ion channel antagonist.
  2. NMDA receptor antagonist

    Memantine hydrochloride is an antagonist at the NMDA receptor, binding to the ion channel site. it was used in the treatment of Parkinsonism.
  3. NMDA antagonist

    Non-opioid analgesic with muscle relaxant properties.
  4. NMDA receptor antagonist

    7-Chlorokynurenic acid sodium salt is a potent and selective antagonist of the glycine B coagonist site of the N-methyl-D-aspartate (NMDA) receptor (IC50=0.56 μM).
  5. NMDA receptor antagonist

    SDZ 220-581 hydrochloride is an orally active, potent, competitive NMDA receptor antagonist with pKi value of 7.7.
  6. NMDA receptor GluN2B antagonist

    Rislenemdaz (CERC-301) is an orally bioavailable and selective N-methyl-D-aspartate (NMDA) receptor subunit 2B (GluN2B) antagonist with Ki and IC50 of 8.1 nM and 3.6 nM, respectively.
  7. NR2C/NR2D-selective NMDA receptor antagonist

    QNZ46 is a NR2C/NR2D-selective NMDA receptor non-competitive antagonist (IC50 values are 3, 6, 229, and >300, >300 μM for NR2D, NR2C, NR2A, NR2B, and GluR1, respectively).
  8. Caroverine hydrochloride is a potent, competitive and reversible antagonist of NMDA and AMPA glutamate receptor. Caroverine hydrochloride is also an antioxidant and calcium-blocking agent that exhibits vasorelaxant action. Caroverine hydrochloride can be used for the research of inner ear tinnitus.
  9. modulator of the GluN2C/D NMDA receptor

    DQP-1105 is a negative allosteric modulator of the GluN2C/D NMDA receptor inhibiting receptor function more potently when glutamate is present .
  10. non-NMDA receptor antagonist

    DNQX Disodium is a water-soluble form of selective non-NMDA receptor antagonist DNQX.
  11. NMDA Receptor Antagonist

    (Rac)-PEAQX is an NMDA receptor antagonist that effectively modulates synaptic transmission by inhibiting NMDA receptor activity. It has demonstrated the ability to activate caspase-3, inducing apoptotic pathways in cortical striatal slice cultures. This compound is valuable for research applications focusing on neurodegenerative diseases, synaptic plasticity, and mechanisms of neuronal apoptosis.
  12. Pregnanolone, also known as eltanolone, is an endogenous inhibitory neurosteroid that is produced in the body from progesterone.

  13. NMDA Receptor Inhibitor

    MN-05 is a dual neuroprotective and vasodilatory inhibitor of the NMDA receptor. By blocking calcium influx, it reduces free radical production and preserves mitochondrial membrane potential in cortical neurons exposed to glutamate. Additionally, MN-05 exhibits vasodilatory effects by dilating aortic rings in response to phenylephrine-induced contraction. This compound demonstrates protective properties against glutamate-induced neuronal injury in vitro, making it valuable for research in neurodegenerative diseases.
  14. NMDA receptor antagonist

    Orphenadrine citrate is a NMDA receptor antagonist with Ki of 6.0 +/- 0.7 μM, HERG potassium channel blocker.
  15. Felbamate is an antagonist at the NMDA-associated glycine binding site.
  16. NMDA Receptor Antagonist

    TCN 201 is a NMDA receptor antagonist selective for NR1/NR2A over NR1/NR2B-containing receptors
  17. NMDA receptor antagonist

    SDZ 220-581 is a competitive NMDA receptor antagonist (pKi = 7.7).
  18. NMDA receptor agonist

    NMDA is a prototypic NMDA receptor agonist.
  19. NMDAR modulator

    GNE 0723 is a brain permeable positive allosteric modulator of NMDAR, with an EC50 of 21 nM for GluN2A, 7.4 and 6.2 μM for GluN2C and GluN2D, respectively.
  20. NMDA receptor antagonist

    (+)-MK 801 is a potent antagonist of NMDA with Ki value of 30.5nM.
  21. NMDA antagonist

    Eliprodil is a non-competitive NR2B-NMDA receptor antagonist(IC50=1 uM), less potent for NR2A- and NR2C-containing receptors(IC50> 100 uM).
  22. NMDA receptors Blocker

    Ro 25-6981 is a high-affinity, potent and selective blocker of N-methyl- D-aspartate (NMDA) receptors.
  23. NMDA receptor antagonist

    RPR104632 is a specific antagonist of NMDA receptor, with potent neuroprotective properties.
  24. NMDA receptor antagonist.

    (-)-MK 801 maleate acts as a potent, selective, and non-competitive NMDA receptor antagonist. It acts by binding to a site located within the NMDA associated ion channel.
  25. NMDA receptor antagonist

    GV-196771A is the sodium salt form of GV196771, is an NMDA receptor antagonist.
  26. NMDAR modulator

    GLYX-13 is a selective weak partial agonist of the glycine site of the NMDA receptor which is under development by Naurex as adjunctive therapy for treatment-resistant depression.
  27. NMDA receptor antagonist

    MDL-29951 is a novel glycine antagonist of NMDA receptor activation (Ki=0.14 mM, [3H]glycine binding) in vitro and in vivo.
  28. NMDA receptor antagonist

    DNQX is a non-N-methyl-D-aspartate (non-NMDA) receptor complex antagonist.
  29. NMDA& mGlu receptor agonist

    Ibotenic acid is a neuroexcitatory amino acid originally isolated from Amanita species that functions as a NMDA and metabotropic glutamate receptor agonist.
  30. NMDA receptors antagonist

    NVP-AAM077 inhibited progenitor cells proliferation in the subventricular zone and dentate gyrus and reduced the survival of newborn cells in the dentate gyrus in the adult mice.
  31. NMDA receptor antagonist

    Neu-2000 is a NMDA receptor antagonist potentially for the treatment of stroke.
  32. NMDA antagonist

    D-AP5 is a selective N-methyl-D-aspartate (NMDA) receptor antagonist that competitively inhibits the glutamate binding site of NMDA receptors.
  33. NMDA receptor antagonist

    7CKA is a NMDA receptor antagonist that acts at the glycine site.
  34. Muscarinic antagonist

    Procyclidine hydrochloride is a muscarinic antagonist that crosses the blood-brain barrier and is used in the treatment of drug-induced extrapyramidal disorders and in Parkinsonism.
  35. NMDA receptor antagonist

    Mephenesin is an NMDA receptor antagonist, is a centrally acting muscle relaxant.
  36. NMDA antagonist

    AZD-4282, also known as aminoacetic acid and glycine, is a N-methyl-D-aspartate (NMDA) receptor antagonist potentially for the treatment of neuropathic pain.
  37. NMDA glutamate receptor co-agonist

    (R)-Serine, an endogenous amino acid involved in glia-synapse interactions that has unique neurotransmitter characteristics, is a potent co-agonist at the NMDA glutamate receptor.
  38. NMDA antagonist

    CGS 19755 (cis-4-phosphonomethyl-2-piperidine carboxylic acid) was found to be a potent, stereospecific inhibitor of N-methyl-D-aspartate (NMDA)-evoked, but not KCl-evoked, [3H] acetylcholine release from slices of the rat striatum.
  39. NMDA receptors blocker

    Ro 25-6981 Maleate is a potent and selective activity-dependent blocker of NMDA receptors containing the NR2B subunit. IC50 values are 0.009 and 52 uM for cloned receptor subunit combinations NR1C/NR2B and NR1C/NR2A respectively.
  40. AMPA/kainate antagonist

    CNQX is a competitive, non-NMDA glutamate receptor antagonist (IC50s = 0.3 and 1.5 uM for AMPA and kainate receptors, respectively, versus IC50 = 25 uM for NMDA receptors).
  41. NMDA receptor antagonist

    Ifenprodil tartrate is the atypical N-methyl-D-aspartate (NMDA) receptor antagonist, inhibits NMDA-induced currents at NR1A/NR2B receptors with high affinity (IC50 = 0.34 μM).
  42. excitatory transmitter/agonist

    L-Glutamic acid monosodium salt acts as an excitatory transmitter and an agonist at all subtypes of glutamate receptors (metabotropic, kainate, NMDA, and AMPA). (S)-Glutamic acid shows a direct activating effect on the release of DA from dopaminergic terminals.
  43. GlyT inhibitor/NMDA receptor

    Sarcosine is a glycine transporter type 1 (GlyT) inhibitor and an N-methyl-D-aspartate (NMDA) receptor co-agonist at the glycine binding site.
  44. DL-AP5 is the racemic version of the selective N-methyl-D-aspartate (NMDA) receptor antagonist.
  45. NMDA receptor agonist

    Quinolinic acid is an endogenous N-methyl-D-aspartate (NMDA) receptor agonist synthesized from L-tryptophan via the kynurenine pathway and thereby has the potential of mediating N-methyl-D-aspartate neuronal damage and dysfunction.
  46. NMDA receptor antagonist

    Perzinfotel (EAA-090) is a potent, selective, and competitive NMDA receptor antagonist with neuroprotective effects. Perzinfotel (EAA-090) shows high affinity (IC50=30 nM) for the glutamate site.
  47. NMDA antagonist

    UK-240455 is a potent and selective N-methyl D-aspartate (NMDA) glycine site antagonist.
  48. NMDA receptor agonist

    (-)-Aspartic acid is an endogenous NMDA receptor agonist.
  49. NMDA receptor antagonist

    Transcrocetinate disodium, extracted from saffron (Crocus sativus L.), acts as an NMDA receptor antagonist with high affinity.
  50. NMDA receptor antagonist

    MDL 105519 is a potent and selective antagonist of glycine binding to the NMDA receptor.

Items 1-50 of 209

Page
per page
Set Descending Direction